Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 3, 2023, Karuna Therapeutics, Inc. (the "Company") and Charmaine
Lykins mutually agreed that Ms. Lykins will depart from the Company effective
January 5, 2023. The Company expects to enter into a separation agreement with
Ms. Lykins that provides for a general release and waiver of claims against the
Company, and pursuant to which Ms. Lykins will receive the severance benefits
that are provided for under Section 5(b) of her Employment Agreement effective
November 29, 2021 as a result of her departure.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses